Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Jun 2022	67	Global Markets Direct	ASDR-607655

Published: Jun 2022 - Pages : 67 - Publisher : Global Markets Direct - Report code : ASDR-607655

Accendatech Co Ltd
Advanced Vision Technologies (New York)
Astellas Pharma Inc
Beam Therapeutics Inc
Jazz Pharmaceuticals Plc
MDI Therapeutics Inc
Second Genome Inc

Plasminogen Activator Inhibitor 1 - Pipeline Review, H2 2020

This report can be of interest as well:

Plasminogen Activator Inhibitor 1 - Pipeline Review, H2 2020

Published: October, 2020 | Report code: ASDR-567887

Mark your calendar:

Veterans Affairs Healthcare Summit

23 July - 24 July, 2024
Arlington, United States